Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
ESMO
oncology
cancer
Gilead Sciences
Bristol Myers Squibb
Zymeworks
Amgen
Adaptimmune Therapeutics
TCR2 Therapeutics
Boehringer Ingelheim
Study: 1/3 of Cancer Accelerated Approval Indications Remain Despite Lack of Confirmation
BioSpace
Mon, 09/13/21 - 11:31 pm
FDA
accelerated approvals
cancer
oncology
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Gilead Sciences
Regeneron
AstraZeneca
FDA
PROs
oncology
clinical trials
patient-reported outcomes
Study: Youth cancer trials should collect more patient-reported data for interventions
Fierce Biotech
Thu, 08/19/21 - 11:12 am
clinical trials
patient-reported outcomes
cancer
pediatric
oncology
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Fierce Biotech
Tue, 08/17/21 - 10:26 am
Eli Lilly
reorganization
Loxo Oncology
oncology
Neuroscience
Alzheimer's disease
Analysis: Real-world studies of cancer drugs suffer from poor quality
RAPS.org
Thu, 08/12/21 - 12:13 am
oncology
cancer
RWE
real world evidence
real world data
With an assist from AstraZeneca, the salvage crew at Sierra bets another $216M they can resurrect an old Gilead JAK drug
Endpoints
Fri, 08/6/21 - 11:07 am
Gilead Sciences
AstraZeneca
Sierra Oncology
AZD5153
oncology
Biotech startup using AI to take guesswork out of cancer drug selection raises $70M
MedCity News
Thu, 07/8/21 - 11:45 pm
Xilis
artificial intelligence
funding
cancer
oncology
Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer
Endpoints
Thu, 07/1/21 - 11:09 pm
Merck
Keytruda
oncology
stomach cancer
FDA
Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like buyers: analysts
Fierce Pharma
Mon, 06/28/21 - 11:54 am
M&A
Joe Biden
Biogen
Gilead Sciences
oncology
gene therapy
FDA encourages including incurable cancer patients in trials, regardless of prior therapies
Endpoints
Thu, 06/24/21 - 12:33 pm
FDA
cancer
oncology
clinical trials
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
drug development
MannKind
Thirona Bio
pulmonary fibrosis
Oyster Point Pharma
Adaptive Phage Therapeutics
ophthalmic
Takeda
Codexis
ALX Oncology
Eli Lilly
clinical trials
BeiGene
Shoreline Biosciences
oncology
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
ASCO 2021
Sanofi
Sloane Kettering
Incyte
AstraZeneca
Exelixis
oncology
COVID-19 impact on oncology clinical trials: a 1-year analysis
Nature
Tue, 05/18/21 - 11:41 pm
COVID-19
pandemic
oncology
clinical trials
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Endpoints
Tue, 05/11/21 - 11:10 am
Thorsten Graef
Pharmacyclics
AbbVie
oncology
Acepodia
NK cells
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
Fierce Pharma
Fri, 05/7/21 - 10:39 am
biosimilars
oncology
immunology
autoimmune disease
cancer
Trillium unveils CD47 clinical research priorities as investors await solid tumor data
Fierce Biotech
Wed, 04/28/21 - 10:52 am
Trillium Therapeutics
CD47
solid tumors
oncology
cancer
GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out
Fierce Biotech
Wed, 04/28/21 - 10:47 am
GSK
oncology
Immunocore
Duchenne Muscular Dystrophy
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
FDA
oncology
accelerated approvals
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »